ReviewClinical immunology (Orlando, Fla.)2024

Optimizing iNKT-driven immune responses against cancer by modulating CD1d in tumor and antigen presenting cells.

Ritis Kumar Shyanti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.